The latest US Supreme Court ruling on pesticide lawsuits has suddenly changed the risk profile for a handful of agricultural chemical stocks, especially those tied to glyphosate and paraquat products. With thousands of potential cases now blocked and federal rules taking clear priority over state warning labels, legal uncertainty has eased for companies at the center of this story. For investors, that kind of clarity can be just as important as earnings or growth projections. This article walks through 3 stocks from the Pesticide Litigation Relief Stocks With Legal Tailwinds screener that are directly exposed to this news and explains what that may mean for their risk and return trade offs.

FMC (FMC)

Overview: FMC is a US agricultural sciences company that develops and sells crop protection chemicals such as insecticides, herbicides, fungicides, as well as biologicals, nutrition and seed treatment products to farmers across the Americas, EMEA and Asia through its own sales teams and distribution partners.

Operations: FMC generates its revenue primarily from its Innovative Solutions segment, which contributed about US$3.4b.

Market Cap: US$1.4b

FMC sits at the center of the glyphosate and paraquat debate, and the recent Supreme Court ruling that limits state-level lawsuits removes a key legal overhang for EPA approved products. This may appeal to investors who are watching litigation risk. At the same time, FMC is rebuilding profitability, with analysts expecting an earnings recovery and a return to positive margins, while the stock trades on a low P/S of 0.4x and a price that is below some fair value estimates. On the other hand, the company carries meaningful debt, its dividend is not well covered, and it is reshaping its footprint by selling the India business and raising new secured debt. The key question for investors is whether FMC can translate its product pipeline and patent enforcement into the cash flow repair the market is watching for.

FMC’s low P/S, litigation relief and portfolio reshaping hint at a valuation story many investors may be underestimating, but the balance between debt, dividends and cash flow repair is crucial to the DCF valuation analysis for FMC

Corteva (CTVA)

Overview: Corteva is a global agriculture company that supplies farmers with seeds and crop protection products, including traited seeds, herbicides and insecticides, as well as digital tools that help improve yields and farm profitability across major growing regions worldwide.

Operations: Corteva generates most of its revenue from its Seed segment at about US$10.2b, with its Crop Protection segment contributing roughly US$7.7b.

Market Cap: US$52.9b

Corteva sits at the heart of the seed and crop protection market, and the Supreme Court ruling that limits state level failure to warn lawsuits removes a meaningful overhang for its herbicide portfolio while reinforcing EPA authority. Combined with the recent settlement with Bayer that resolves long running seed litigation and gives Corteva broader licensing opportunities, this legal clarity comes as analysts highlight expectations for earnings growth, margin expansion and a more focused, higher quality earnings mix from the planned spin. The stock is not cheap on headline P/E, and past one off losses and reliance on external funding mean you still need to watch earnings quality and balance sheet risk. However, the mix of legal relief, product pipeline and potential valuation gap is one reason Corteva remains on many investors’ radars.

Corteva’s legal overhang is easing just as the earnings mix is being reshaped, but the full story sits in how the moving parts fit together in the analysis report for Corteva

Nufarm (ASX:NUF)

Overview: Nufarm is an Australian agricultural chemicals and seeds company that supplies herbicides, insecticides, fungicides and seed technologies that help farmers protect crops and improve yields across Europe, the Middle East, Africa, North America and the Asia Pacific.

Operations: Nufarm generates most of its revenue from Crop Protection in North America at about A$1.3b and Europe at about A$908m, with Crop Protection in APAC at about A$808m and Seed Technologies globally contributing around A$365m.

Market Cap: A$1.0b

Nufarm stands out on this screener because it is directly exposed to glyphosate while sitting on a low P/S multiple and a valuation framework that points to a wide gap between price and estimated fair value, just as the Supreme Court ruling reduces the risk of US product liability lawsuits. At the same time, the company is working through high leverage and a history of losses, with management focused on margins, cost savings and a pipeline that includes higher value seed and specialty crop products. For investors watching the turn in crop protection pricing, the potential for deleveraging and the legal tailwind around glyphosate, the key issue is how these moving pieces affect future earnings quality and resilience.

Nufarm’s valuation gap, legal tailwind and push into higher value products could be masking where the real upside sits, so it is worth reviewing the analyst forecasts for Nufarm before one crucial piece of the story comes into focus.

Take Control of Your Investment Journey

If Corteva or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Others Catch On?

Fresh ideas can move fast and the best breakouts are often caught while they are still under the radar. For now, before momentum sends prices higher, consider positioning earlier in the trend.

• Spot stronger income anchors by scanning curated companies in the 7 dividend fortresses that aim to keep cash returns coming even when growth stories fall out of favor.
• Track early technology momentum with the hand picked 49 AI infrastructure stocks that may be positioned to benefit as AI demand affects data centers and power capacity, before pricing fully reflects that story.
• Focus on financial durability across markets by reviewing the list of solid balance sheet and fundamentals (48 results) so you are less likely to hold companies with fragile cash flows when conditions change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.